Metabolic imaging via fluorescence lifetime imaging microscopy for egg and embryo assessment
Noninvasive metabolic imaging via fluorescence life- time imaging microscopy allows egg and embryo viability assessment in vitro.
Volume 111, Issue 2, Pages 212–218
Tim Sanchez, Ph.D., Man Zhang, M.D., Ph.D., Dan Needleman, Ph.D., Emre Seli, M.D.
Current strategies for embryo assessment in the assisted reproductive technology laboratories rely primarily on morphologic parameters that have limited accuracy for determining embryo viability. Even with the addition of invasive diagnostic interventions such as preimplantation genetic testing for aneuploidy alone or in combination with mitochondrial DNA copy number assessment, at least one third of embryos fail to implant. Therefore, at a time when the clinical benefits of single ET are widely accepted, improving viability assessment of embryos is ever more important. Building on the previous work demonstrating the importance of metabolic state in oocytes and embryos, metabolic imaging via fluorescence lifetime imaging microscopy offers new and potentially useful diagnostic method by detecting natural fluorescence of FAD and NADH, the two electron transporters that play a central role in oxidative phosphorylation. Recent studies demonstrate that fluorescence lifetime imaging microscopy can detect oocyte and embryo metabolic function and dysfunction in a multitude of experimental models and provide encouraging evidence for use in scientific investigation and possibly for clinical application.